Cargando…
Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19
Background: Lactate dehydrogenase (LDH) has been proved to be a prognostic factor for the severity and poor outcomes of coronavirus disease 2019 (COVID-19). In most studies, patients with various levels of COVID-19 severity were pooled and analyzed which may prevent accurate evaluation of the relati...
Autores principales: | Dong, Xingtong, Sun, Lu, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484664/ https://www.ncbi.nlm.nih.gov/pubmed/32922185 http://dx.doi.org/10.7150/ijms.47604 |
Ejemplares similares
-
Serum lactate dehydrogenase level is associated with in-hospital mortality in critically Ill patients with acute kidney injury
por: Zhang, Dan, et al.
Publicado: (2021) -
The Added Value of Lactate and Lactate Clearance in Prediction of In-Hospital Mortality in Critically Ill Patients With Sepsis
por: Baysan, Meryem, et al.
Publicado: (2020) -
The prognostic value of delta‐lactate in critically ill children
por: Rocha, Ana C, et al.
Publicado: (2022) -
Prognostic value of preoperative serum lactate dehydrogenase levels for resectable gastric cancer and prognostic nomograms
por: Wang, Zi-Xian, et al.
Publicado: (2016) -
Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19
por: Li, Chang, et al.
Publicado: (2020)